Sun Pharma offers to buy remaining stake in Taro

19 Oct 2011 Evaluate

Sun Pharmaceutical, which had initiated acquisition of Taro Pharmaceutical Industries four-and-a-half years ago, made a proposal to be the 100 per cent owner of the West Asian drug company. After about three years of legal battle, Sun had in last September completed the acquisition of controlling stake in the Israeli firm. Today, Sun Pharma, the country’s largest drugmaker by market cap, owns 66 per cent in Taro.Sun has offered to buy all of the outstanding shares it does not own in Taro — for $24.40 a share. Tts offer represents 25.96 per cent premium over the most recent closing of the Israeli firm's common stock. The offer is subject to the approval of Taro Board and other regulatory authorities.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×